THP-1 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Essential facts about THP-1 cells
| Description | THP1 cells, a spontaneously immortalized monocyte-like cell line derived from the peripheral blood of a 1-year-old monocytic leukemia patient, serve as a critical model in immunological and cancer research. The THP-1 monocyte cell line, known for its ability to differentiate into mature macrophage and dendritic cells, is essential for studying the functions and properties of these immune cells in vitro, including adipose tissue macrophages and M2 mononuclear phagocytes. THP-1 differentiated macrophages are instrumental in exploring monocyte and macrophage functions, mechanisms, signalling pathways, including cytokine activation and immune modulation, and studying nutrient and drug transport. Further, THP-1 macrophages can be polarized into M1 or M2 macrophages, crucial for studies on immunity and inflammation, innate immunity, and inflammatory responses. In the context of metabolic and inflammatory diseases, THP-1 cells help explore cytokine profiles, including inflammatory cytokines, and their impact on conditions like human adipocyte apoptosis, illustrating the interplay between inflammation and metabolic health. Notably, the THP-1 cell line allows for comparative studies with other monocytic leukemia cells and cell lines like U937, facilitating a deeper understanding of monocyte and macrophage biology across different models. In summary, the THP-1 human monocytic leukemia cell line stands as a valuable tool for a myriad of research avenues, from investigating the intricate mechanisms of the immune system and its role in cancer to understanding the cellular and molecular underpinnings of immune modulation, cytokine activation, and cell proliferation. Its ability to mimic human macrophages and dendritic cells, combined with the ease of manipulation and fast growth rate, cements its status as a widely used cell line in biological and medical research, offering insights into the cellular basis of immunity and inflammation, the response of cancer cells, and the potential for therapeutic intervention. |
|---|---|
| Organism | Human |
| Tissue | The tissue of origin is peripheral blood |
| Disease | Leukemia |
| Applications | THP1 cells are a multifacted model with applications in Immune response modeling, Monocyte/macrophage differentiation, Phagocytosis mechanisms, Inflammatory signaling pathways, Drug transport assays |
| Synonyms | THP1, THP 1, THPI, O-THP-1, Tohoku Hospital Pediatrics-1 |
Specifications
| Age | 1 year |
|---|---|
| Gender | Male |
| Morphology | Round cells |
| Cell type | Monocyte |
| Growth properties | The monocytic leukemia THP1 cell line grows in suspension and forms clumps due to cells dividing and attaching to the clusters they split from. |
Documentation
| Citation | THP-1 (Cytion catalog number 300356) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0006 |
Genetic profile of the THP1 cell line
| Receptors expressed | HLA haplotypes: HLA-A2, -A9, -B5, -DRw1, -DRw2Fc, C3b |
|---|---|
| Isoenzymes | The human THP-1 cell line expresses low levels of CD4, CCR5, and CxCR4, making it relevant to HIV infection studies. However, they express low levels of CD14 and not CD80, CD86, CD11b, CD11c, Mertk, or CD1a, making them a poor model for primary monocytes regarding LPS responses. |
| Products | Lysozyme |
| Karyotype | THP-1 cells are near-diploid and contain two related subclones with genetic aberrations. |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS |
| Doubling time | The population doubling time of human THP-1 cells ranges from 19 to 50 hours, with an average of around 35 hours. |
| Subculturing | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Seeding density | 0.5 x 106 cells/mL |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality control
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300356-211124 | Certificate of Analysis | 23. May. 2025 | 300356 |
| 300356-200625 | Certificate of Analysis | 18. Aug. 2025 | 300356 |
| 300356-050424 | Certificate of Analysis | 23. May. 2025 | 300356 |